BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 16574902)

  • 1. Absence of TRAM restricts Toll-like receptor 4 signaling in vascular endothelial cells to the MyD88 pathway.
    Harari OA; Alcaide P; Ahl D; Luscinskas FW; Liao JK
    Circ Res; 2006 May; 98(9):1134-40. PubMed ID: 16574902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF.
    Fitzgerald KA; Rowe DC; Barnes BJ; Caffrey DR; Visintin A; Latz E; Monks B; Pitha PM; Golenbock DT
    J Exp Med; 2003 Oct; 198(7):1043-55. PubMed ID: 14517278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of lipopolysaccharide-inducible genes by MyD88 and Toll/IL-1 domain containing adaptor inducing IFN-beta.
    Hirotani T; Yamamoto M; Kumagai Y; Uematsu S; Kawase I; Takeuchi O; Akira S
    Biochem Biophys Res Commun; 2005 Mar; 328(2):383-92. PubMed ID: 15694359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
    Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
    J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.
    Youn HS; Lee JY; Saitoh SI; Miyake K; Kang KW; Choi YJ; Hwang DH
    Biochem Pharmacol; 2006 Sep; 72(7):850-9. PubMed ID: 16890209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
    Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
    PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha.
    Sato N; Takahashi N; Suda K; Nakamura M; Yamaki M; Ninomiya T; Kobayashi Y; Takada H; Shibata K; Yamamoto M; Takeda K; Akira S; Noguchi T; Udagawa N
    J Exp Med; 2004 Sep; 200(5):601-11. PubMed ID: 15353553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the porcine alveolar macrophages via toll-like receptor 4/NF-κB mediated pathway provides a mechanism of resistin leading to inflammation.
    Li B; Fang J; Zuo Z; Yin S; He T; Yang M; Deng J; Shen L; Ma X; Yu S; Wang Y; Ren Z; Cui H
    Cytokine; 2018 Oct; 110():357-366. PubMed ID: 29655569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIF signaling is essential for TLR4-driven IgE class switching.
    Janssen E; Ozcan E; Liadaki K; Jabara HH; Manis J; Ullas S; Akira S; Fitzgerald KA; Golenbock DT; Geha RS
    J Immunol; 2014 Mar; 192(6):2651-8. PubMed ID: 24532577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta2-adrenergic receptor regulate Toll-like receptor 4-induced late-phase NF-kappaB activation.
    Kizaki T; Shirato K; Sakurai T; Ogasawara JE; Oh-ishi S; Matsuoka T; Izawa T; Imaizumi K; Haga S; Ohno H
    Mol Immunol; 2009 Mar; 46(6):1195-203. PubMed ID: 19167076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling.
    Sacre SM; Lundberg AM; Andreakos E; Taylor C; Feldmann M; Foxwell BM
    J Immunol; 2007 Feb; 178(4):2148-54. PubMed ID: 17277119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling.
    Naiki Y; Michelsen KS; Zhang W; Chen S; Doherty TM; Arditi M
    J Biol Chem; 2005 Feb; 280(7):5491-5. PubMed ID: 15623538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
    Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
    J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Tat Protein Activates both the MyD88 and TRIF Pathways To Induce Tumor Necrosis Factor Alpha and Interleukin-10 in Human Monocytes.
    Planès R; Ben Haij N; Leghmari K; Serrero M; BenMohamed L; Bahraoui E
    J Virol; 2016 Jul; 90(13):5886-5898. PubMed ID: 27053552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
    Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
    Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKT1 distinctively suppresses MyD88-depenedent and TRIF-dependent Toll-like receptor signaling in a kinase activity-independent manner.
    Zenke K; Muroi M; Tanamoto KI
    Cell Signal; 2018 Mar; 43():32-39. PubMed ID: 29242168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface immunogenic protein from Streptococcus agalactiae and
    Díaz-Dinamarca DA; Salazar ML; Escobar DF; Castillo BN; Valdebenito B; Díaz P; Manubens A; Salazar F; Troncoso MF; Lavandero S; Díaz J; Becker MI; Vásquez AE
    Front Immunol; 2023; 14():1186188. PubMed ID: 37790926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.